메뉴 건너뛰기




Volumn 61, Issue 7, 2015, Pages 1189-1195

Age at Entry into Care, Timing of Antiretroviral Therapy Initiation, and 10-Year Mortality among HIV-Seropositive Adults in the United States

Author keywords

aging; antiretroviral therapy; epidemiologic methods; HIV

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

EID: 84942156184     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/civ463     Document Type: Article
Times cited : (35)

References (17)
  • 1
    • 64349118898 scopus 로고    scopus 로고
    • Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: A collaborative analysis of 18 HIV cohort studies
    • Sterne JAC, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-63
    • (2009) Lancet , vol.373 , pp. 1352-1363
    • Jac, S.1    May, M.2    Costagliola, D.3
  • 2
    • 65449167169 scopus 로고    scopus 로고
    • Effect of early versus deferred antiretroviral therapy for HIV on survival
    • Kitahata MM, Gange SJ, Abraham AG, et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009; 360:1815-26
    • (2009) N Engl J Med , vol.360 , pp. 1815-1826
    • Kitahata, M.M.1    Gange, S.J.2    Abraham, A.G.3
  • 3
    • 80053377142 scopus 로고    scopus 로고
    • Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters
    • Funk MJ, Fusco JS, Cole SR, et al. Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med 2011; 171:1560-9
    • (2011) Arch Intern Med , vol.171 , pp. 1560-1569
    • Funk, M.J.1    Fusco, J.S.2    Cole, S.R.3
  • 4
    • 79955422390 scopus 로고    scopus 로고
    • When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIVinfected persons in developed countries: An observational study
    • Cain LE, Logan R, Robins JM, et al. When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIVinfected persons in developed countries: an observational study. Ann Intern Med 2011; 154:509-15
    • (2011) Ann Intern Med , vol.154 , pp. 509-515
    • Cain, L.E.1    Logan, R.2    Robins, J.M.3
  • 5
    • 80053051431 scopus 로고    scopus 로고
    • Comparative effectiveness of dynamic treatment regimes: An application of the parametric g-formula
    • Young JG, Cain LE, Robins JM, O'Reilly EJ, Hernán MA. Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci 2011; 3:119-43
    • (2011) Stat Biosci , vol.3 , pp. 119-143
    • Young, J.G.1    Cain, L.E.2    Robins, J.M.3    O'Reilly, E.J.4    Hernán, M.A.5
  • 6
    • 80051633217 scopus 로고    scopus 로고
    • Prevention of HIV-1 infection with early antiretroviral therapy
    • Cohen MS, Chen YQ, McCauleyM, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505
    • (2011) N Engl J Med , vol.365 , pp. 493-505
    • Cohen, M.S.1    Chen, Y.Q.2    McCauley, M.3
  • 7
    • 0031303666 scopus 로고    scopus 로고
    • The incubation period of AIDS
    • Muñoz A, Sabin CA, Phillips AN. The incubation period of AIDS. AIDS 1997; 11(suppl A):S69-76
    • (1997) AIDS , vol.11 , pp. S69-76
    • Muñoz, A.1    Sabin, C.A.2    Phillips, A.N.3
  • 8
    • 0037072066 scopus 로고    scopus 로고
    • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies
    • Egger M, May M, Chêne G, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360:119-29
    • (2002) Lancet , vol.360 , pp. 119-129
    • Egger, M.1    May, M.2    Chêne, G.3
  • 9
    • 53349098905 scopus 로고    scopus 로고
    • Cohort profile: The Centers for AIDS Research Network of Integrated Clinical Systems
    • Kitahata MM, Rodriguez B, Haubrich R, et al. Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems. Int J Epidemiol 2008; 37:948-55
    • (2008) Int J Epidemiol , vol.37 , pp. 948-955
    • Kitahata, M.M.1    Rodriguez, B.2    Haubrich, R.3
  • 10
    • 84924052633 scopus 로고    scopus 로고
    • The parametric g-formula for time-to-event data intuition and a worked example
    • Keil A, Edwards JK, Richardson DB, Naimi AI, Cole SR. The parametric g-formula for time-to-event data intuition and a worked example. Epidemiology 2014; 25:889-97
    • (2014) Epidemiology , vol.25 , pp. 889-897
    • Keil, A.1    Edwards, J.K.2    Richardson, D.B.3    Naimi, A.I.4    Cole, S.R.5
  • 11
    • 84864000886 scopus 로고    scopus 로고
    • The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death
    • Westreich D, Cole SR, Young JG, et al. The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med 2012; 31:2000-9
    • (2012) Stat Med , vol.31 , pp. 2000-2009
    • Westreich, D.1    Cole, S.R.2    Young, J.G.3
  • 12
    • 33845382806 scopus 로고
    • Nonparametric estimation from incomplete observations
    • Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81
    • (1958) J Am Stat Assoc , vol.53 , pp. 457-481
    • Kaplan, E.L.1    Meier, P.2
  • 14
    • 0022973522 scopus 로고
    • Identifiability, exchangeability, and epidemiological confounding
    • Greenland S, Robins JM. Identifiability, exchangeability, and epidemiological confounding. Int J Epidemiol 1986; 15:413-9
    • (1986) Int J Epidemiol , vol.15 , pp. 413-419
    • Greenland, S.1    Robins, J.M.2
  • 16
    • 84904247190 scopus 로고    scopus 로고
    • Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators
    • Edwards JK, Cole SR, Westreich D, et al. Loss to clinic and five-year mortality among HIV-infected antiretroviral therapy initiators. PLoS One 2014; 9:e102305
    • (2014) PLoS One , vol.9 , pp. e102305
    • Edwards, J.K.1    Cole, S.R.2    Westreich, D.3
  • 17
    • 78651467125 scopus 로고    scopus 로고
    • Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial
    • Cole SR, Stuart EA. Generalizing evidence from randomized clinical trials to target populations: the ACTG 320 trial. Am J Epidemiol 2010; 172:107-15
    • (2010) Am J Epidemiol , vol.172 , pp. 107-115
    • Cole, S.R.1    Stuart, E.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.